Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Maurizio Bonacini, M.D.

Maurizio Bonacini, M.D.Dr. Bonacini is an associate clinical professor at the University of California-San Francisco and the director of the HIV-Liver program at California Pacific Medical Center. Dr. Bonacini is an authority on issues of hepatology and HIV; he has been the lead author of dozens of peer-reviewed, published studies on hepatitis C and liver damage, and his research frequently focuses specifically on HIV-infected patients. In addition to his role as an active researcher and principal investigator in a number of clinical trials, Dr. Bonacini has also authored several book chapters on liver disease, hepatotoxicity and other comorbidities, and is a frequent presenter at major scientific gatherings at which hepatic concerns are a focus.

A native of Lecce, Italy, Dr. Bonacini now lives in San Francisco, Calif., with his wife and two children. Dr. Bonacini completed his medical education in Brussels, Belgium, where he earned his M.D. from the Université Catholique de Louvain School of Medicine. He completed his internship and medical residency at Booth Memorial Medical Center in New York City, and went on to complete two fellowships: one in gastroenterology at Los Angeles County-University of Southern California Medical Center and the other in hepatology at the University of Southern California.

Dr. Bonacini is a member of the abstract review committee of the American Association for the Study of Liver Diseases, and has taken part in editorial reviews for a number of reputable medical journals, including the American Journal of Gastroenterology, Clinical Infectious Diseases, Hepatology and the Journal of AIDS.

Disclosures

Dr. Bonacini is a member of Boehringer Ingelheim's hepatic safety advisory boards for nevirapine (Viramune) and tipranavir (Aptivus).




  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

 

Tools
 

Advertisement